GlassScriptPhysician profile
John J Rich
NPI 1265438659
$7,467.96
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,554 · 2020: $1,072 · 2021: $1,103 · 2022: $991 · 2023: $1,227 · 2024: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,323.59 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $927.50 | 2019-2024 | |
| Amgen INC. | $697.77 | 2019-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $669.96 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $669.05 | 2019-2024 | Farxiga, Andexxa |
| Boston Scientific Corporation | $536.81 | 2019-2024 | Watchman Flx |
| Heartflow, INC. | $464.66 | 2022-2024 | Ffrct |
| Amarin Pharma, INC. | $187.86 | 2019-2021 | |
| Pfizer INC. | $174.12 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.51 | 2021-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $163.34 | 2019-2023 | |
| Shockwave Medical, INC | $156.06 | 2022 | |
| Abbott Laboratories | $152.89 | 2019-2024 | Gallant |
| Regeneron Healthcare Solutions, INC. | $134.78 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $132.71 | 2023 | Assure Wcd |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $122.12 | 2021-2023 | Verquvo, Steglatro |
| Actelion Pharmaceuticals US, INC. | $113.36 | 2019-2023 | Opsumit |
| Novo Nordisk INC | $85.43 | 2019-2023 | Rybelsus, Ozempic |
| Lundbeck LLC | $71.89 | 2019-2020 | |
| Cvrx, INC. | $62.38 | 2022-2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $56.50 | 2020-2023 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $50.34 | 2022-2023 | |
| Lantheus Medical Imaging, INC. | $44.02 | 2019 | |
| Getinge USA Sales, LLC | $39.00 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $34.44 | 2022-2023 | Arcalyst |
| Vifor Pharma, INC. | $27.70 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $25.37 | 2019 | |
| Alnylam Pharmaceuticals INC. | $24.60 | 2020-2021 | |
| Daiichi Sankyo INC. | $24.38 | 2024 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $24.00 | 2020-2021 | |
| Teleflex LLC | $23.51 | 2023 | Arrow |
| Beckman Coulter, INC. | $22.65 | 2019 | |
| Edwards Lifesciences Corporation | $19.65 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $16.49 | 2024 | Arcalyst |
| Abiomed | $13.31 | 2020 | |
| United Therapeutics Corporation | $12.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.